Tacrolimus (FK506) increases neuronal expression of GAP-43 and improves functional recovery after spinal cord injury in rats

Experimental Neurology

Volumn 154, Issue 2, 1998, Pages 673-683

  Madsen, Joseph R ^a,b   MacDonald, Paul ^a   Irwin, Nina ^a   Goldberg, David E ^a   Yao, Gui Lan ^a   Meiri, Karina F ^d   Rimm, Ilonna J ^a   Stieg, Philip E ^a,b   Benowitz, Larry I ^a,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

FK506; GAP 43; Immunophilin; Neurite outgrowth; Photothrombotic lesion; Spinal cord injury; Sprouting; Tacrolimus

Indexed keywords

CALCINEURIN; FK 506 BINDING PROTEIN; MESSENGER RNA; NEUROMODULIN; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FUNCTIONAL ASSESSMENT; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIGAND BINDING; NERVE FIBER GROWTH; NERVE SPROUTING; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SPINAL CORD INJURY;

EID: 0032411557     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1998.6974     Document Type: Article

References (43)

1. Aigner L., Arber S., Kapfhammer J. P., Laux T., Schneider C., Botteri F., Brenner H. R., Caroni P. Overexpression of the neural growth-associated protein GAP-43 induces nerve sprouting in the adult nervous system of transgenic mice. Cell. 83:1995;269-278.
2. Aigner L., Caroni P. Absence of persistent spreading, branching, and adhesion in GAP-43-depleted growth cones. J. Cell Biol. 128:1995;647-660.
3. Armistead D. M., Badia M. C., Deininger D. D., Duffy J. P., Saunders J. O., Tung R. D., Thomson J. A., Decenzo M. T., Futer O., Liningston D. J., Murcko M. A., Yamashita M. M., Navia M. A. Design, synthesis and structure of non-macrocyclic inhibitors of FKBP12, the major binding protein for the immunosuppressant FK506. Acta Crystallogr. 51:1995;522-528.
4. Bartholdi D., Schwab M. E. Methylprednisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat. Brain Res. 672:1995;177-186.
5. Basso D. M., Beattie M. S., Bresnahan J. C. A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma. 12:1995;1-21.
6. Benowitz L. I., Apostolides P. J., Perrone-Bizzozero N. I., Finklestein S. P., Zwiers H. Anatomical distribution of the growth-associated protein GAP-43/B-50 in the adult rat brain. J. Neurosci. 8:1988;990-995.
7. Benowitz L. I., Routtenberg A. GAP-43: An intrinsic determinant of neuronal development and plasticity. Trends Neurosci. 20:1997;84-91.
8. Bierer B. E. Biology of cyclosporin A and FK506. Prog. Clin. Biol. Res. 390:1994;203-223.
9. Butcher S. P., Henshall D. C., Teramura Y., Kazuhide I., Sharkey J. Neuroprotective actions of FK506 in experimental stroke: In vivo evidence against an antiexcitotoxic mechanism. J. Neurosci. 17:1997;6939-6946.
10. Butt A. M., Kirvell S. Glial cells in transected optic nerves of immature rats. II. An immunohistochemical study. J. Neurocytol. 25:1996;381-392.
11. Cheng H., Cao Y., Olson L. Spinal cord repair in adult paraplegic rats: Partial restoration of hind limb function. Science. 273:1996;510-513.
12. Costello B., Meymandi A., Freeman J. A. Factors influencing GAP-43 gene expression in PC12 pheochromocytoma cells. J. Neurosci. 10:1990;1398-1406.
13. Curtis R., Green D., Lindsay R. M., Wilkin G. P. Up-regulation of GAP-43 and growth of axons in rat spinal cord after compression injury. J. Neurocytol. 22:1993;51-64.
14. Dokas L. A., Pisano M. R., Han Y. F. Selective phosphorylation and dephosphorylation of the protein B-50. Prog. Brain Res. 89:1991;27-36.
15. Fehlings M. G., Tator C. H. The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury. Exp. Neurol. 132:1995;220-228.
16. Gold B. G., Katoh K., Storm D. T. The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerve. J. Neurosci. 15:1995;7509-7516.
17. Gold B. G., Yew J. Y., Zeleny-Pooley M. The immunosuppressant FK506 increases GAP-43 mRNA levels in axotomized sensory neurons. Neurosci. Lett. 241:1998;25-28.
18. Gold B. G., Zeleny-Pooley M., Wang M.-S., Chaturvedi P., Armistead D. M. A non-immunosuppressant FKBP-12 ligand increases nerve regeneration. Exp. Neurol. 147:1997;269-278.
19. Han Y. F., Wang W., Schlender K. K., Ganjeizadeh M., Dokas L. A. Protein phosphatases 1 and 2A dephosphorylate B-50 in presynaptic plasma membranes from rat brain. J. Neurochem. 59:1992;364-374.
20. Hayashi K., Nagamatsu T., Ito M., Suzuki Y. Suppression of experimental crescentic-type anti-glomerular basement membrane (GBM) nephritis by FK506 (tacrolimus hydrate) in rats. Jpn. J. Pharmacol. 70:1996;43-54.
21. Irwin N., Madsen J. R. Molecular biology of axonal outgrowth. 1. Growth cones and GAP-43. Ped. Neurosurgery. 27:1997;113-120.
22. Karns L. R., Ng S. C., Freeman J. A., Fishman M. C. Cloning of complementary DNA for GAP-43, a neuronal growth-related protein. Science. 236:1987;597-600.
23. Kehl L. J., Fairbanks C. A., Laughlin T. M., Wilcox G. L. Neurogenesis in postnatal rat spinal cord: A study in primary culture. Science. 276:1997;586-589.
24. Linda H., Piehl F., Dagerlind A., Verge V. M., Arvidsson U., Cullheim S., Risling M., Ulfhake B., Hokfelt T. Expression of GAP-43 mRNA in the adult mammalian spinal cord under normal conditions and after different types of lesions, with special reference to motoneurons. Exp. Brain Res. 91:1992;284-295.
25. Liu Y. C., Storm D. R. Dephosphorylation of neuromodulin by calcineurin. J. Biol. Chem. 264:1989;12800-12804.
26. Lyons W. E., George E. B., Dawson T. M., Steiner J. P., Snyder S. H. Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia. Proc. Natl. Acad. Sci. USA. 91:1994;3191-3195.
27. Meiri K. F., Bickerstaff L. E., Schwob J. E. Monoclonal antibodies show that kinase C phosphorylation of GAP-43 during axonogenesis is both spatially and temporally restricted in vivo. J. Cell Biol. 112:1991;991-1005.
28. Naso W. B., Perot P. J., Cox R. D. The neuroprotective effect of high-dose methylprednisolone in rat spinal cord hemisection. Neurosci. Lett. 189:1995;176-178.
29. Prado R., Dietrich W. D., Watson B. D., Ginsberg M. D., Green B. A. Photochemically induced graded spinal cord infarction: Behavioral, electrophysiological, and morphological correlates. J. Neurosurg. 67:1987;745-753.
30. Schreyer D. J., Skene J. H. Fate of GAP-43 in ascending spinal axons of DRG neurons after peripheral nerve injury: Delayed accumulation and correlation with regenerative potential. J. Neurosci. 11:1991;3738-3751.
31. Sharkey J., Butcher S. P. Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia. Nature. 371:1994;336-339.
32. Skene J. H. P. Axonal growth-associated proteins. Annu. Rev. Neurosci. 12:1989;127-156.
33. Steiner J. P., Connolly M. A., Valentine H. L., Hamilton G. S., Dawson T. M., Hester L., Snyder S. H. Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A. Nat. Med. 3:1997;421-428.
34. Steiner J. P., Dawson T. M., Fotuhi M., Glatt C. E., Snowman A. M., Cohen N., Snyder S. H. High brain densities of the immunophilin FKBP colocalized with calcineurin. Nature. 358:1992;584-587.
35. Steiner J. P., Hamilton G. S., Ross D. T., Valentine H. L., Guo H., Connolly M. A., Liang S., Ramsey C., Li J. J., Huang W., Howorth P., Soni R., Fuller M., Sauer H., Nowotnik A. C., Suzdak P. D. Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. Proc. Natl. Acad. Sci. USA. 94:1997;2019-2024.
36. Strittmatter S. M., Fankhauser C., Huang P. L., Mashimo H., Fishman M. C. Neuronal pathfinding is abnormal in mice lacking the neuronal growth cone protein GAP-43. Cell. 80:1995;445-452.
37. Tator C. H. Biology of neurological recovery and functional restoration after spinal cord injury. Neurosurgery. 42:1998;696-708.
38. Thanos S., Mey J., Wild M. Treatment of the adult retina with microglia-suppressing factors retards axotomy-induced neuronal degradation and enhances axonal regeneration in vivo and in vitro. J. Neurosci. 13:1993;455-466.
39. Widmer F., Caroni P. Phosphorylation-site mutagenesis of the growth-associated protein GAP-43 modulates its effects on cell spreading and morphology. J. Cell Biol. 120:1993;503-512.
40. Woolf C. J., Reynolds M. L., Molander C., O'Brien C., Lindsay R. M., Benowitz L. I. The growth-associated protein GAP-43 appears in dorsal root ganglion cells and in the dorsal horn of the rat spinal cord following peripheral nerve injury. Neuroscience. 34:1990;465-478.
41. Xu J., Qu Z. X., Hogan E. L., Perot P. J. Protective effect of methylprednisolone on vascular injury in rat spinal cord injury. J. Neurotrauma. 9:1992;245-253.
42. Yao G. L., Kiyama H. Dexamethasone enhances level of GAP-43 mRNA after nerve injury and facilitates re-projection of the hypoglossal nerve. Brain Res. Mol. Brain Res. 32:1995;308-312.
43. Yao G. L., Kiyama H., Tohyama M. Distribution of GAP-43 (B50/F1) mRNA in the adult rat brain by in situ hybridization using an alkaline phosphatase labeled probe. Brain Res. Mol. Brain Res. 18:1993;1-16.